Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ys Biopharma Co. Ltd (YS)

Ys Biopharma Co. Ltd (YS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 71,655
  • Shares Outstanding, K 93,058
  • Annual Sales, $ 100,000 K
  • Annual Income, $ -21,170 K
  • 60-Month Beta 0.52
  • Price/Sales 0.91
  • Price/Cash Flow N/A
  • Price/Book 1.10
Trade YS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.03
  • Most Recent Earnings $-0.16 on 01/22/24
  • Latest Earnings Date 04/19/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7000 +0.57%
on 04/19/24
1.0285 -31.55%
on 04/04/24
-0.0159 (-2.21%)
since 03/28/24
3-Month
0.3503 +100.97%
on 02/02/24
1.0285 -31.55%
on 04/04/24
+0.2582 (+57.92%)
since 01/30/24
52-Week
0.3503 +100.97%
on 02/02/24
1.9400 -63.71%
on 05/01/23
-1.2660 (-64.26%)
since 04/28/23

Most Recent Stories

More News
YS Biopharma Announces First Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine

/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...

YS : 0.7040 (-8.57%)
YS Biopharma Granted Patent in the U.S. for Immunotherapy Targeting Chronic Hepatitis B Virus Infection

/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...

YS : 0.7040 (-8.57%)
YS Biopharma to Participate in Participate in Citi's 18th Annual Biopharma Conference

/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...

YS : 0.7040 (-8.57%)
YS Biopharma Announces Purchase of Shares by Company Officers

/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...

YS : 0.7040 (-8.57%)
YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024

/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...

YS : 0.7040 (-8.57%)
YS Biopharma Announces Financial Results for Fiscal Year 2023 Ended March 31, 2023

/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...

YS : 0.7040 (-8.57%)
YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023

/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...

YS : 0.7040 (-8.57%)
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages YS Biopharma Co., Ltd. f/k/a Summit Healthcare Acquisition Corp. Investors to Inquire About Securities Class Action Investigation - YS, SMIH

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of YS...

YS : 0.7040 (-8.57%)
YS Biopharma's PIKA Rabies Vaccine Receives Phase 3 Clinical Trial Approval From Philippines FDA

/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...

YS : 0.7040 (-8.57%)
YS Biopharma to Participate in the Virtual Benchmark Healthcare House Call Conference on May 23, 2023

/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...

YS : 0.7040 (-8.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

YS Biopharma Co. Ltd. is a biopharmaceutical company. It focuses on discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The company operates principally in China, the United States, Singapore, the United...

See More

Key Turning Points

3rd Resistance Point 0.8307
2nd Resistance Point 0.8053
1st Resistance Point 0.7547
Last Price 0.7040
1st Support Level 0.6787
2nd Support Level 0.6533
3rd Support Level 0.6027

See More

52-Week High 1.9400
Fibonacci 61.8% 1.3327
Fibonacci 50% 1.1452
Fibonacci 38.2% 0.9576
Last Price 0.7040
52-Week Low 0.3503

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar